BIOMAT Database Logo BIOMAT Database Logo

Periodic fluctuations in resistance of a myeloma tumor (MOPC-315-el) to cytotoxic T lymphocytes. 1981

A H Hale, and J H Russell, and A D d'Angeac, and M Panetti, and B Hazelton, and H N Eisen

UI MeSH Term Description Entries
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A H Hale, and J H Russell, and A D d'Angeac, and M Panetti, and B Hazelton, and H N Eisen
Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
September 1988, Cancer research,
A H Hale, and J H Russell, and A D d'Angeac, and M Panetti, and B Hazelton, and H N Eisen
A monoclonal antiidiotypic antibody to MOPC 315 IgA inhibits the growth of MOPC 315 myeloma cells in vitro.
January 1981, Journal of immunology (Baltimore, Md. : 1950),
A H Hale, and J H Russell, and A D d'Angeac, and M Panetti, and B Hazelton, and H N Eisen
Lymphocyte surface membrane immunoglobulin in myeloma. I. M315-bearing T lymphocytes in mice with MOPC-315.
September 1979, Journal of immunology (Baltimore, Md. : 1950),
A H Hale, and J H Russell, and A D d'Angeac, and M Panetti, and B Hazelton, and H N Eisen
Binding of antigen-bearing fluorescent liposomes to the murine myeloma tumor MOPC 315.
February 1979, Journal of immunology (Baltimore, Md. : 1950),
A H Hale, and J H Russell, and A D d'Angeac, and M Panetti, and B Hazelton, and H N Eisen
Thermodynamics of hapten binding to MOPC 315 and MOPC 460 mouse myeloma proteins.
January 1974, Biochemistry,
A H Hale, and J H Russell, and A D d'Angeac, and M Panetti, and B Hazelton, and H N Eisen
Effect of syngeneic tumor tRNA on MOPC 315 myeloma in BALB-cCR mouse.
January 1973, Journal of surgical oncology,
A H Hale, and J H Russell, and A D d'Angeac, and M Panetti, and B Hazelton, and H N Eisen
Importance of tumor-specific cytotoxic CD8+ T-cells in eradication of a large subcutaneous MOPC-315 tumor following low-dose melphalan therapy.
December 1990, Cancer research,
A H Hale, and J H Russell, and A D d'Angeac, and M Panetti, and B Hazelton, and H N Eisen
Presence of an enlarged pool of MOPC-315-specific cytotoxic T lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapy.
January 1990, Cancer immunology, immunotherapy : CII,
A H Hale, and J H Russell, and A D d'Angeac, and M Panetti, and B Hazelton, and H N Eisen
Intratumor maturational heterogeneity within the murine myeloma MOPC-315.
January 1981, Cancer research,
A H Hale, and J H Russell, and A D d'Angeac, and M Panetti, and B Hazelton, and H N Eisen
Protection of adult BALB/c mice against MOPC 315 myeloma by neonatal administration of monoclonal anti-idiotypic antibody to MOPC 315 IgA.
September 1986, Journal of the National Cancer Institute,
Copied contents to your clipboard!